GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Ventana Biotech Inc (OTCPK:VNTA) » Definitions » Change In Receivables

VNTA (Ventana Biotech) Change In Receivables : $0.00 Mil (TTM As of . 20)


View and export this data going back to 2008. Start your Free Trial

What is Ventana Biotech Change In Receivables?

Ventana Biotech's change in receivables for the quarter that ended in . 20 was $0.00 Mil. It means Ventana Biotech's Accounts Receivable stayed the same from . 20 to . 20 .

Ventana Biotech's change in receivables for the fiscal year that ended in . 20 was $0.00 Mil. It means Ventana Biotech's Accounts Receivable stayed the same from . 20 to . 20 .

Ventana Biotech's Accounts Receivable for the quarter that ended in . 20 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ventana Biotech's liquidation value for the six months ended in . 20 was $0.00 Mil.

Ventana Biotech Change In Receivables Historical Data

The historical data trend for Ventana Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventana Biotech Change In Receivables Chart

Ventana Biotech Annual Data
Trend
Change In Receivables

Ventana Biotech Semi-Annual Data
Change In Receivables

Ventana Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ventana Biotech  (OTCPK:VNTA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ventana Biotech's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=/*91
=

2. In Ben Graham's calculation of liquidation value, Ventana Biotech's accounts receivable are only considered to be worth 75% of book value:

Ventana Biotech's liquidation value for the quarter that ended in . 20 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=-+0.75 * +0.5 *
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ventana Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ventana Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventana Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Ventana Biotech Inc (OTCPK:VNTA) » Definitions » Change In Receivables
Comparable Companies
EMAX LSMG FBDS PCMC FSTJ KATX TRXA HGYN ATYG RMHI PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
1660 South Albion Street, Suite 1007, Denver, CO, USA, 80222
Website
https://www.launchpadcafe.net
Ventana Biotech Inc is a development stage company providing alternative financing in the capacity of a broker for those commercial borrowers in need of non-bank financing.